Evidence map›Paper›PMID 36700869›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2023

Letter to the editor: Importance of considering high-risk behaviours in COVID-19 vaccine effectiveness estimates with observational studies.

Takeshi Arashiro, Yuzo Arima, Jin Kuramochi, Hirokazu Muraoka, Akihiro Sato, Kumi Chubachi, Kunihiro Oba, Atsushi Yanai, Hiroko Arioka, Yuki Uehara and 18 more

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

28 authors.

Takeshi ArashiroCenter for Surveillance, Immunization, and Epidemiologic Research, National Institute of Infectious Diseases, Tokyo, Japan.
Yuzo ArimaCenter for Surveillance, Immunization, and Epidemiologic Research, National Institute of Infectious Diseases, Tokyo, Japan.
Jin KuramochiKuramochi Clinic Interpark, Tochigi, Japan.
Hirokazu MuraokaCLINIC FOR Tamachi, Tokyo, Japan.
Akihiro SatoKARADA Internal Medicine Clinic, Tokyo, Japan.
Kumi ChubachiChubachi Internal Respiratory Medicine Clinic, Tokyo, Japan.
Kunihiro ObaDepartment of Pediatrics, Showa General Hospital, Tokyo, Japan.
Atsushi YanaiDepartment of General Internal Medicine, St. Luke's International Hospital, Tokyo, Japan.
Hiroko AriokaDepartment of General Internal Medicine, St. Luke's International Hospital, Tokyo, Japan.
Yuki UeharaDepartment of Clinical Laboratory, St. Luke's International Hospital, Tokyo, Japan.
Genei IharaMachida Ekimae Naika Clinic, Tokyo, Japan.
Yasuyuki KatoDepartment of Infectious Diseases, International University of Health and Welfare Narita Hospital, Chiba, Japan.
Naoki YanagisawaYanagisawa Clinic, Tokyo, Japan.
Yoshito NaguraShinjuku Home Clinic, Tokyo, Japan.
Hideki YanaiFukujuji Hospital, Japan Anti-Tuberculosis Association, Kiyose, Japan.
Akihiro UedaDepartment of Infectious Diseases, Japanese Red Cross Medical Center, Tokyo, Japan.
Akira NumataIkebukuro Metropolitan Clinic, Tokyo, Japan.
Hideaki KatoInfection Prevention and Control Department, Yokohama City University Hospital, Yokohama, Japan.
Hideaki OkaDepartment of General Internal Medicine and Infectious Diseases, Saitama Medical Center, Saitama, Japan.
Yusuke NishidaDepartment of General Internal Medicine and Infectious Diseases, Saitama Medical Center, Saitama, Japan.
Takao OokiSaitama Sekishinkai Hospital, Saitama, Japan.
Yuki NidairaKuramochi Clinic Interpark, Tochigi, Japan.
Ashley StuckyCenter for Surveillance, Immunization, and Epidemiologic Research, National Institute of Infectious Diseases, Tokyo, Japan.
Tadaki SuzukiDepartment of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.
Chris SmithFaculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Martin HibberdFaculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Koya AriyoshiSchool of Tropical Medicine and Global Health, Nagasaki University, Nagasaki, Japan.
Motoi SuzukiCenter for Surveillance, Immunization, and Epidemiologic Research, National Institute of Infectious Diseases, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19 VaccinesRisk-TakingCOVID-19HumansObservational Studies as TopicVaccine EfficacyCOVID-19 VaccinesbehaviourCOVID-19physical distancingSARS-CoV-2test-negative designvaccine effectiveness

Identifiers

PMID36700869
PMCPMC9881180

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.